Lowell Blake & Associates Inc. Novo Nordisk A S Transaction History

Lowell Blake & Associates Inc.

$1.4 Billion
Q3 2023

A detailed history of Lowell Blake & Associates Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Lowell Blake & Associates Inc. holds 34,610 shares of NVO stock, worth $4.67 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

34,610

Previous 14,781 134.15%

Holding current value

$4.67 Million

Previous $2.39 Million 31.56%

% of portfolio

0.22%

Previous 0.69%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $1.8 Million - $3.96 Million	19,829 Added 134.15%	34,610 $3.15 Million
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $1,091 - $1,208	-7 Reduced 0.05%	14,781 $2.39 Million
Q1 2023 May 12, 2023	BUY	$132.34 - $159.14 $114,738 - $137,974	867 Added 6.23%	14,788 $2.35 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $37,540 - $46,070	394 Added 2.91%	13,921 $1.39 Million
Q2 2022 Aug 11, 2022	SELL	$103.24 - $121.81 $20,648 - $24,362	-200 Reduced 1.46%	13,527 $1.51 Million
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $166,649 - $201,446	1,790 Added 15.0%	13,727 $1.52 Million
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $244,494 - $298,554	-2,550 Reduced 17.6%	11,937 $1.34 Million
Q3 2021 Oct 15, 2021	BUY	$84.42 - $106.62 $42,210 - $53,310	500 Added 3.57%	14,487 $1.39 Million
Q2 2021 Jul 29, 2021	BUY	$67.66 - $84.76 $100,204 - $125,529	1,481 Added 11.84%	13,987 $1.17 Million
Q1 2021 May 06, 2021	BUY	$67.06 - $75.82 $574,637 - $649,701	8,569 Added 217.65%	12,506 $843,000
Q4 2020 Feb 04, 2021	BUY	$63.89 - $73.8 $3,897 - $4,501	61 Added 1.57%	3,937 $275,000
Q3 2020 Oct 22, 2020	SELL	$63.69 - $70.22 $11,846 - $13,060	-186 Reduced 4.58%	3,876 $269,000
Q2 2020 Aug 13, 2020	BUY	$58.54 - $67.94 $18,264 - $21,197	312 Added 8.32%	4,062 $266,000
Q4 2019 Jul 01, 2020	BUY	$49.86 - $58.26 $186,975 - $218,475	3,750 New	3,750 $217,000

Others Institutions Holding NVO

# of Institutions

1,991

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $304B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowell Blake & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lowell Blake & Associates Inc. with notifications on news.

Account

Lowell Blake & Associates Inc. Novo Nordisk A S Transaction History